GBI Research, Dec 2009, Pages: 81
delves deep into the respiratory market potential in various indications such as pulmonary hypertension, cystic fibrosis, asthma, and Chronic Obstructive Pulmonary Disease (COPD), and provides insights
Frost & Sullivan, March 2011, Pages: 91
Trends in Indoor Air Quality in Buildings This research service provides a detailed insight into the overall technology developments in the indoor air quality domain. The service starts off
Merchant Research and Consulting Ltd., July 2011, Pages: 71
.
Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
The report will help you to find prospective partners and suppliers.
The annual
Frost & Sullivan, Jan 1998
Biotech Revolution, The (Technical Insights) Technical Insights brings you up-to-date on the biotech revolution sweeping medicine and industry. Packed with valuable technical and market data
Business Insights, Jan 2008, Pages: 101
and asthma, but the successful positioning of combination products remains difficult in therapeutic areas where combination therapies only provide marginally incremental benefits. Launching Combination
Business Insights, May 2008, Pages: 175
Leading Drug Delivery Companies and Technologies: Competitive Landscape, Company Profiles and Technological Developments Business Insights' portfolio of healthcare management reports is designed
Takeda Pacific, Sep 2006, Pages: 163
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices This research study is about drug delivery systems. It provides readers with relevant information, insights
IDTechEx, April 2012, Pages: 136
types of sensors.
Printed and flexible sensors represent the latest in the development of devices that extend the humanoid's primary sensory abilities, giving specific exploratory insight
GBI Research, Feb 2011, Pages: 100
research and in-house analysis by GBI Research’s team of industry experts.
The report gives insight about the key deals which have taken place between biopharmaceutical companies and their influence. Reasons
GBI Research, Nov 2011, Pages: 143
and capitalize. GBI Research’s new report, “GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing”, provides insights into the technical and commercial importance of G protein coupled
GlobalData, March 2012, Pages: 40
, 2011: New ATS Guideline Recommending Measurement Of FENO In Asthma Management A Significant Milestone For Company: Aerocrine
Aug 15, 2011: Aerocrine Appoints Morten Gunvad As Vice President Commercial
GlobalData, Sep 2011, Pages: 41
company, engaged in the development and manufacturing of products and services pertaining to asthma management and care. The company markets its flagship products under the brand name of Niox. The company
GlobalData, Sep 2010, Pages: 26
Cobalis Corporation (CLSC) - Financial and Strategic Analysis Review Cobalis Corp. (Cobalis) is a specialty pharmaceutical company engaged in the developing and commercializing pharmaceutical
Business Insights, Aug 2006, Pages: 156
.
'The Future of Metabolomics' provides detailed insight into the effective use of metabolomics throughout drug discovery, preclinical development and clinical trials. The report also highlights the use
Datamonitor, Dec 2010, Pages: 182
Stakeholder Insight: COPD in Emerging Markets (Brazil, India, China, US) - Key differences in treatment despite standardized guidelines Introduction
While general COPD treatment patterns
Markets and Markets, Feb 2011, Pages: 264
and provide sufficient basis of ranking top ten drug delivery technologies.
REASONS FOR DOING THE STUDY:
More than 25% of the marketed drugs fail to provide expected commercial returns due to drug
Business Insights, June 2007, Pages: 244
to the market.
‘Outlook for RNAi 2007’ is a new report which provides a detailed insight into the most effective use of this noveltechnology in the drug discovery and development process.
It puts into context where RNAi
GlobalData, May 2011, Pages: 35
company engaged in the research, development and commercialization of medical devices in Australia, Israel and the US. The company is specialized in developing innovative non-invasive acoustic tools
